In-vitro development of an effective treatment for Acanthamoeba keratitis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2017/09/01
-
Indian UGC (journal)
-
Refrences43
-
Citations22
-
Á. Ortillés
-
J. Belloc
-
E. Rubio
-
M.T. Fernández
-
M. Benito
-
J.Á. Cristóbal
-
B. Calvo
-
P. Goñi
Cite
Ortillés, Á., et al. “In-Vitro Development of an Effective Treatment for Acanthamoeba Keratitis”. International Journal of Antimicrobial Agents, vol. 50, no. 3, 2017, pp. 325-33, https://doi.org/10.1016/j.ijantimicag.2017.03.033.
Ortillés, Á., Belloc, J., Rubio, E., Fernández, M., Benito, M., Cristóbal, J., Calvo, B., & Goñi, P. (2017). In-vitro development of an effective treatment for Acanthamoeba keratitis. International Journal of Antimicrobial Agents, 50(3), 325-333. https://doi.org/10.1016/j.ijantimicag.2017.03.033
Ortillés, Á., J. Belloc, E. Rubio, M.T. Fernández, M. Benito, J.Á. Cristóbal, B. Calvo, and P. Goñi. “In-Vitro Development of an Effective Treatment for Acanthamoeba Keratitis”. International Journal of Antimicrobial Agents 50, no. 3 (2017): 325-33. https://doi.org/10.1016/j.ijantimicag.2017.03.033.
Ortillés Á., Belloc J, Rubio E, Fernández M, Benito M, Cristóbal J, et al. In-vitro development of an effective treatment for Acanthamoeba keratitis. International Journal of Antimicrobial Agents. 2017;50(3):325-33.
Journal Categories
Medicine
Internal medicine
Infectious and parasitic diseases
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Microbiology
You May Also Like
- Identification of acquired antimicrobial resistance genes
- Determination of minimum inhibitory concentrations
- Synergy, antagonism, and what the chequerboard puts between them
- Antibacterial Activity and Mode of Action of Ferulic and Gallic Acids Against Pathogenic Bacteria
- Does the Wide Use of Quaternary Ammonium Compounds Enhance the Selection and Spread of Antimicrobial Resistance and Thus Threaten Our Health?
Refrences
Refrences Analysis
The category
Medicine: Medicine (General) 20
is the most frequently represented among the references in this article. It primarily includes studies from Cornea and Antimicrobial Agents and Chemotherapy. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones | Life |
| 2024 | |
| 5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii | Acta Tropica |
| 2 | 2022 |
| Amoebicidal effect of Allium cepa against Allovahlkampfia spelaea: A keratitis model | Saudi Pharmaceutical Journal |
| 2022 | |
| An Update on the Initial Treatment of Acanthamoeba Keratitis | International Ophthalmology Clinics | 2022 | ||
Stimulation of Acanthamoeba castellanii excystment by enzyme treatment and consequences on trophozoite growth | Frontiers in Cell and Developmental Biology |
| 2 | 2022 |
Citations Analysis
The category
Medicine: Internal medicine: Infectious and parasitic diseases 6
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B and was published in 2017. The most recent citation comes from a 2024 study titled Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones. This article reached its peak citation in 2022, with 6 citations. It has been cited in 20 different journals, 30% of which are open access. Among related journals, the Current Eye Research cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.